awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37931886-62C01047-5520-47F3-B50E-2E3056FFB3C5
Q37931886-62C01047-5520-47F3-B50E-2E3056FFB3C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37931886-62C01047-5520-47F3-B50E-2E3056FFB3C5
Bevacizumab in non-small-cell lung cancer: a review.
P2860
Q37931886-62C01047-5520-47F3-B50E-2E3056FFB3C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37931886-62C01047-5520-47F3-B50E-2E3056FFB3C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
871d296e77c81d85a587c9c885ccb17f16921d8e
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.